MIRM · Company research
Mirum Pharmaceuticals, Inc. Common Stock (MIRM): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals (MIRM) Stock Looks Reasonable After Positive Phase 3 Results - Simply Wall Street | Mirum Pharmaceuticals (MIRM) Stock Looks Reasonable After Positive Phase 3 Results Simply Wall Street | View source ↗ | Simply Wall Street | Oct 17, 2026 | neutral | 0 | 0.6 |
| Mirum Pharmaceuticals, Inc. (MIRM) stock price, news, quote and history - Yahoo Finance UK | Mirum Pharmaceuticals, Inc. (MIRM) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 16, 2026 | neutral | 0 | 0.6 |
| How Phase 3 Trial Success Will Impact Mirum Stock Investors - Simply Wall Street | How Phase 3 Trial Success Will Impact Mirum Stock Investors Simply Wall Street | View source ↗ | Simply Wall Street | Oct 15, 2026 | neutral | 0 | 0.6 |
| MIRM Jan 2027 180.000 call (MIRM270115C00180000) Interactive Stock Chart - Yahoo! Finance Canada | MIRM Jan 2027 180.000 call (MIRM270115C00180000) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| MIRM Oct 2026 45.000 put (MIRM261016P00045000) Interactive Stock Chart - Yahoo Finance - Yahoo! Finance Canada | MIRM Oct 2026 45.000 put (MIRM261016P00045000) Interactive Stock Chart - Yahoo Finance Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| Medical chief receives 40,000 options and a 25,000-share stock grant at Mirum Pharmaceuticals (MIRM). - Stock Titan | Medical chief receives 40,000 options and a 25,000-share stock grant at Mirum Pharmaceuticals (MIRM). Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Mirum's Livmarli Meets Phase III Goal in Ultra-Rare Liver Diseases | Mirum Pharmaceuticals announced that its Phase III EXPAND study met the primary endpoint for Livmarli (maralixibat) in treating cholestatic pruritus in patients with ultra-rare cholestatic liver diseases. Livmarli showed a 1.81-point improvement in itch severity versus 0.83 for placebo and achieved a 69% reduction in serum bile acids. The company plans to submit a supplemental new drug application to the FDA in the first half of 2027. Livmarli sales have grown 50.2% year-over-year in the first half of 2026, reaching $242.5 million. | View source ↗ | Zacks Investment Research | Oct 13, 2026 | bullish | 0.667 | 1 |
| Mirum's Livmarli Meets Phase III Goal in Ultra-Rare Liver Diseases | Mirum Pharmaceuticals announced that its Phase III EXPAND study met the primary endpoint for Livmarli (maralixibat) in treating cholestatic pruritus in patients with ultra-rare cholestatic liver diseases. Livmarli showed a 1.81-point improvement in itch severity versus 0.83 for placebo and achieved a 69% reduction in serum bile acids. The company plans to submit a supplemental new drug application to the FDA in the first half of 2027. Livmarli sales have grown 50.2% year-over-year in the first half of 2026, reaching $242.5 million. | View source ↗ | Zacks Investment Research | Oct 13, 2026 | bullish | 0.667 | 1 |
| Understanding Momentum Shifts in (MIRM) - Stock Traders Daily | Understanding Momentum Shifts in (MIRM) Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 13, 2026 | neutral | 0 | 0.6 |
| Why Is Mirum Pharmaceuticals Stock Gaining Monday? - Benzinga | Why Is Mirum Pharmaceuticals Stock Gaining Monday? Benzinga | View source ↗ | Benzinga | Oct 12, 2026 | neutral | 0 | 0.6 |
| Mirum Pharmaceuticals, Inc. (MIRM) Stock Price, News, Quote & History - Yahoo! Finance Canada | Mirum Pharmaceuticals, Inc. (MIRM) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 12, 2026 | neutral | 0 | 0.6 |
| Citizens Says FDA’s 'Unexpected' Phase 3 Request Clouds Mirum’s Near-Term Outlook – MIRM Stock Crashes 15% - Stocktwits | Citizens Says FDA’s 'Unexpected' Phase 3 Request Clouds Mirum’s Near-Term Outlook – MIRM Stock Crashes 15% Stocktwits | View source ↗ | Stocktwits | Oct 11, 2026 | neutral | 0 | 0.6 |
| Mirum Pharmaceuticals, Inc. - common stock (Nasdaq:MIRM) Stock Quote - FinancialContent | Mirum Pharmaceuticals, Inc. - common stock (Nasdaq:MIRM) Stock Quote FinancialContent | View source ↗ | FinancialContent | Oct 10, 2026 | neutral | 0 | 0.6 |
| Mirum Pharmaceuticals (MIRM) Hits Its Primary Endpoint, Is The Stock Still Undervalued? - Simply Wall Street | Mirum Pharmaceuticals (MIRM) Hits Its Primary Endpoint, Is The Stock Still Undervalued? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 6, 2026 | neutral | 0 | 0.6 |
| Is Mirum Pharmaceuticals (MIRM) Undervalued On New Brelo Vitug Trial Data? - Yahoo Finance | Is Mirum Pharmaceuticals (MIRM) Undervalued On New Brelo Vitug Trial Data? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 29, 2026 | neutral | 0 | 0.6 |
| An experimental hepatitis D drug met virus and liver targets in 56% of patients; none in the delayed-treatment group did. - Stock Titan | An experimental hepatitis D drug met virus and liver targets in 56% of patients; none in the delayed-treatment group did. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Mirum Pharmaceuticals Falls 7.1% as Investors Appear to Reassess Near-Term Biotech Catalysts | MIRM Stock News - Quiver Quantitative | Mirum Pharmaceuticals Falls 7.1% as Investors Appear to Reassess Near-Term Biotech Catalysts | MIRM Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 18, 2026 | neutral | 0 | 0.6 |
| Mirum Pharmaceuticals Stock Sinks as Widening Quarterly Loss Offsets Raised Full-Year Sales Guidance - TIKR.com | Mirum Pharmaceuticals Stock Sinks as Widening Quarterly Loss Offsets Raised Full-Year Sales Guidance TIKR.com | View source ↗ | TIKR.com | Aug 11, 2026 | neutral | 0 | 0.6 |
| MIRM Forecast — Price Target — Prediction for 2027 - TradingView | MIRM Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Mirum Pharmaceuticals Stock Surges 18%, With A 8-Day Winning Spree - Trefis | Mirum Pharmaceuticals Stock Surges 18%, With A 8-Day Winning Spree Trefis | View source ↗ | Trefis | Jun 26, 2026 | neutral | 0 | 0.6 |
| MIRM Stock Clocks Best Day In 4.5 Months On Liver Disease Trial Data: Retail Eyes Buyout At A Premium - Stocktwits | MIRM Stock Clocks Best Day In 4.5 Months On Liver Disease Trial Data: Retail Eyes Buyout At A Premium Stocktwits | View source ↗ | Stocktwits | May 4, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.